As President Biden continues to release infrastructure spending packages, Democrats are asking the President to consider including many of their health policy priorities in the packages. One of their most prominent requests is for the inclusion of aspects of H.R. 3, the Elijah Cummings Lower Drug Costs Now bill. The bill gained national attention last spring, after President Trump failed to mention it in a speech about tackling “big pharma,” particularly its proposal to allow the federal government to negotiate drug prices directly. Opponents of H.R. 3 raise many concerns, including that it could stifle drug innovations by depressing pharmaceutical company profits. With a new Administration, Democrats hope that many of the bill’s tenets will be signed into law. For more on how the bill tries to control drug costs, keep reading.
Read More >>>

Or open document to read more; page 2.

View PDF